Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

29 May 20264 min read0 viewsJournal Feed

GIST (Key Takeaways)

Artificial intelligence (AI) is a transformative technology that has captivated the medical world with its potential to optimize cancer treatment and enhance precision oncology. In cancer diagnosis and treatment, various AI technologies have already provided high-level data examination and analytics that preceding innovations were not capable of.
Cancer immunotherapy is a treatment that seeks to boost the immune system to recognize and eradicate tumors. It is a field that is constantly evolving, serving as a fertile environment where AI technologies can accelerate discovery and personalize its regimens.
In recent years, AI has played an increased role in the optimization of immunotherapy delivery and drug development. Traditional machine learning and its subfield of deep learning algorithms have already impacted response prediction and related tasks, such as patient stratification for immune checkpoint blockade treatment and identifying potent T-cells in the laboratory to develop effective cellular therapies.
Additionally, recently developed technologies such as generative AI (gen AI) and foundation models have expanded upon traditional AI algorithms with new applications such as treatment plan generation and adverse event prediction.